2 reports

From that price standpoint, the efficacy delivery wasn' t enough.

  • Medical Biotechnology
  • Oncology
  • Japan
  • Demand
  • Remicade group

MESALAMINE IS ONE OF THE MOST EXTENSIVELY USED DRUG AMONGST ALL ##-ASA AGENTS.

  • Autoimmune Disease
  • Oncology
  • Japan
  • Demand
  • Remicade group